List of Synthetic Biologics, Inc. patents

Patents where

Current Assignee

Name

Synthetic Biologics, Inc.

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11517614 Microbiome protection from oral antibiotics	Patent 11517614 was granted and assigned to Synthetic Biologics, Inc. on December, 2022 by the United States Patent and Trademark Office.		Synthetic Biologics, Inc.	United States Patent and Trademark Office	11517614	December 6, 2022
‌ US Patent 11338020 Alkaline phosphatase agents for treatment of neurodevelopmental disorders			Synthetic Biologics, Inc.	United States Patent and Trademark Office	11338020	May 24, 2022
‌ US Patent 9301995 Modified beta-lactamases and methods and uses related thereto	Patent 9301995 was granted and assigned to Synthetic Biologics, Inc. on April, 2016 by the United States Patent and Trademark Office.	Synthetic Biologics, Inc.	Synthetic Biologics, Inc.	United States Patent and Trademark Office	9301995	April 5, 2016
‌ US Patent 9587234 Modified beta-lactamases and methods and uses related thereto	Patent 9587234 was granted and assigned to Synthetic Biologics, Inc. on March, 2017 by the United States Patent and Trademark Office.	Synthetic Biologics, Inc.	Synthetic Biologics, Inc.	United States Patent and Trademark Office	9587234	March 7, 2017
‌ US Patent 11542510 None		Synthetic Biologics, Inc.	Synthetic Biologics, Inc.	United States Patent and Trademark Office	11542510	January 3, 2023
‌ US Patent 9464280 Beta-lactamases with improved properties for therapy	Patent 9464280 was granted and assigned to Synthetic Biologics, Inc. on October, 2016 by the United States Patent and Trademark Office.	Synthetic Biologics, Inc.	Synthetic Biologics, Inc.	United States Patent and Trademark Office	9464280	October 11, 2016
‌ US Patent 9695409 Beta-lactamases with improved properties for therapy	Patent 9695409 was granted and assigned to Synthetic Biologics, Inc. on July, 2017 by the United States Patent and Trademark Office.	Synthetic Biologics, Inc.	Synthetic Biologics, Inc.	United States Patent and Trademark Office	9695409	July 4, 2017
‌ US Patent 9290754 Beta-lactamases with improved properties for therapy	Patent 9290754 was granted and assigned to Synthetic Biologics, Inc. on March, 2016 by the United States Patent and Trademark Office.	Synthetic Biologics, Inc.	Synthetic Biologics, Inc.	United States Patent and Trademark Office	9290754	March 22, 2016
‌ US Patent 9765320 Modified beta-lactamases and methods and uses related thereto	Patent 9765320 was granted and assigned to Synthetic Biologics, Inc. on September, 2017 by the United States Patent and Trademark Office.	Synthetic Biologics, Inc.	Synthetic Biologics, Inc.	United States Patent and Trademark Office	9765320	September 19, 2017
‌ US Patent 11034966 None	Patent 11034966 was granted and assigned to Synthetic Biologics, Inc. on June, 2021 by the United States Patent and Trademark Office.	Synthetic Biologics, Inc.	Synthetic Biologics, Inc.	United States Patent and Trademark Office	11034966	June 15, 2021
‌ US Patent 9034602 Modified beta-lactamases and methods and uses related thereto	Patent 9034602 was granted and assigned to Synthetic Biologics, Inc. on May, 2015 by the United States Patent and Trademark Office.		Synthetic Biologics, Inc.	United States Patent and Trademark Office	9034602	May 19, 2015
‌ US Patent 10041056 Modified beta-lactamases and methods and uses related thereto	Patent 10041056 was granted and assigned to Synthetic Biologics, Inc. on August, 2018 by the United States Patent and Trademark Office.	Synthetic Biologics, Inc.	Synthetic Biologics, Inc.	United States Patent and Trademark Office	10041056	August 7, 2018
‌ US Patent 10046035 Methods and compositions for inhibiting or preventing adverse effects of oral antibiotics	Patent 10046035 was granted and assigned to Synthetic Biologics, Inc. on August, 2018 by the United States Patent and Trademark Office.	Synthetic Biologics, Inc.	Synthetic Biologics, Inc.	United States Patent and Trademark Office	10046035	August 14, 2018
‌ US Patent 8894994 Modified beta-lactamases and methods and uses related thereto	Patent 8894994 was granted and assigned to Synthetic Biologics, Inc. on November, 2014 by the United States Patent and Trademark Office.	Synthetic Biologics, Inc.	Synthetic Biologics, Inc.	United States Patent and Trademark Office	8894994	November 25, 2014
‌ US Patent 10336995 Beta-lactamases with improved properties for therapy	Patent 10336995 was granted and assigned to Synthetic Biologics, Inc. on July, 2019 by the United States Patent and Trademark Office.	Synthetic Biologics, Inc.	Synthetic Biologics, Inc.	United States Patent and Trademark Office	10336995	July 2, 2019
‌ US Patent 10987410 Alkaline phosphatase formulations	Patent 10987410 was granted and assigned to Synthetic Biologics, Inc. on April, 2021 by the United States Patent and Trademark Office.	Synthetic Biologics, Inc.	Synthetic Biologics, Inc.	United States Patent and Trademark Office	10987410	April 27, 2021
‌ US Patent 11253577 Safe and effective beta-lactamase dosing for microbiome protection	Patent 11253577 was granted and assigned to Synthetic Biologics, Inc. on February, 2022 by the United States Patent and Trademark Office.	Synthetic Biologics, Inc.	Synthetic Biologics, Inc.	United States Patent and Trademark Office	11253577	February 22, 2022
‌ US Patent 10548955 Carbapenemases for use with antibiotics for the protection of the intestinal microbiome	Patent 10548955 was granted and assigned to Synthetic Biologics, Inc. on February, 2020 by the United States Patent and Trademark Office.	Synthetic Biologics, Inc.	Synthetic Biologics, Inc.	United States Patent and Trademark Office	10548955	February 4, 2020
‌ US Patent 10087433 Beta-lactamases with improved properties for therapy	Patent 10087433 was granted and assigned to Synthetic Biologics, Inc. on October, 2018 by the United States Patent and Trademark Office.	Synthetic Biologics, Inc.	Synthetic Biologics, Inc.	United States Patent and Trademark Office	10087433	October 2, 2018
‌ US Patent 9376673 Beta-lactamases with improved properties for therapy	Patent 9376673 was granted and assigned to Synthetic Biologics, Inc. on June, 2016 by the United States Patent and Trademark Office.	Synthetic Biologics, Inc.	Synthetic Biologics, Inc.	United States Patent and Trademark Office	9376673	June 28, 2016
‌ US Patent 10584326 Beta-lactamases with improved properties for therapy	Patent 10584326 was granted and assigned to Synthetic Biologics, Inc. on March, 2020 by the United States Patent and Trademark Office.	Synthetic Biologics, Inc.	Synthetic Biologics, Inc.	United States Patent and Trademark Office	10584326	March 10, 2020
‌ US Patent 10011824 Beta-lactamases with improved properties for therapy	Patent 10011824 was granted and assigned to Synthetic Biologics, Inc. on July, 2018 by the United States Patent and Trademark Office.	Synthetic Biologics, Inc.	Synthetic Biologics, Inc.	United States Patent and Trademark Office	10011824	July 3, 2018
‌ US Patent 9301996 Modified beta-lactamases and methods and uses related thereto	Patent 9301996 was granted and assigned to Synthetic Biologics, Inc. on April, 2016 by the United States Patent and Trademark Office.	Synthetic Biologics, Inc.	Synthetic Biologics, Inc.	United States Patent and Trademark Office	9301996	April 5, 2016
‌ US Patent 9404103 Beta-lactamases with improved properties for therapy	Patent 9404103 was granted and assigned to Synthetic Biologics, Inc. on August, 2016 by the United States Patent and Trademark Office.	Synthetic Biologics, Inc.	Synthetic Biologics, Inc.	United States Patent and Trademark Office	9404103	August 2, 2016
‌ US Patent 10709773 Safe and effective beta-lactamase dosing for microbiome protection		Synthetic Biologics, Inc.	Synthetic Biologics, Inc.	United States Patent and Trademark Office	10709773	July 14, 2020

Results per page:

32 results

0 selected

32 results

0 selected